Skip to main content
Account

Peer review reports

From: Monitoring therapeutic efficacy of sunitinib using [18F]FDG and [18F]FMISO PET in an immunocompetent model of luminal B (HER2-positive)-type mammary carcinoma

Original Submission
8 Jan 2015 Submitted Original manuscript
Author responded Author comments
Reviewed Reviewer Report
Reviewed Reviewer Report
Reviewed Reviewer Report
Reviewed Reviewer Report
Reviewed Reviewer Report
Reviewed Reviewer Report
Reviewed Reviewer Report
Resubmission - Version 2
Submitted Manuscript version 2
Reviewed Reviewer Report
Reviewed Reviewer Report
Reviewed Reviewer Report
Resubmission - Version 3
Submitted Manuscript version 3
Publishing
13 Jul 2015 Editorially accepted
22 Jul 2015 Article published 10.1186/s12885-015-1540-2

Learn about peer review

Back to article page

Navigation